Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management

作者：Rossi Roberta Elisa^*; Parisi Ioanna; Despott Edward John; Burroughs Andrew Kenneth; O' Beirne James; Conte Dario; Hamilton Mark Ian; Murray Charles Daniel

来源：World Journal of Gastroenterology, 2014, 20(46): 17352-17359.

DOI：10.3748/wjg.v20.i46.17352

• Inflammatory bowel disease
• Tumour necrosis factor inhibitors
• Hypertransaminasemia
• Drug-related liver injury
• Infliximab

Abnormalities in liver function tests, including transient and self-limiting hypertransaminasemia, cholestatic disease and hepatitis, can develop during treatment with anti-tumour-necrosis-factor (TNF) therapy. The optimal management of liver injury related to anti-TNF therapy is still a matter of debate. Although some authors recommend discontinuing treatment in case of both a rise of alanine aminotransferase more than 5 times the upper limit of normal, or the occurrence of jaundice, there are no standard guidelines for the management of anti-TNF-related liver injury. Bibliographical searches were performed in PubMed, using the following key words: inflammatory bowel disease (IBD); TNF inhibitors; hypertransaminasemia; drug-related liver injury; infliximab. According to published data, elevation of transaminases in patients with IBD treated with anti-TNF is a common finding, but resolution appears to be the usual outcome. Anti-TNF agents seem to be safe with a low risk of causing severe drug-related liver injury. According to our centre experience, we found that hypertransaminasemia was a common, mainly self-limiting finding in our IBD cohort and was not correlated to infliximab treatment on both univariate and multivariate analyses. An algorithm for the management of liver impairment occurring during anti-TNF treatment is also proposed and this highlights the need of a multidisciplinary approach and suggests liver biopsy as a key-point in the management decision in case of severe rise of transaminases. However, hepatic injury is generally self-limiting and drug withdrawal seems to be an exception.

• 出版日期2014-12-14